PHILADELPHIA — In this video exclusive, Pam R. Taub, MD, FACC, cardiologist and associate professor of medicine at University of California, San Diego, highlights the benefits of PCSK9 inhibitors in high-risk patients.
Taub discusses recent data that have demonstrated benefit of PCSK9 inhibitors for reducing major adverse CV events and in subgroups of high-risk patients such as those with multivessel disease, peripheral artery disease, type 2 diabetes and elevated lipoprotein A.
Watch the video for more.
Anupam Ghose, a physician by training, was diagnosed with Type 2 Diabetes Mellitus (T2DM) in 2017. After the diagnosis of T2DM, he followed a low carbohydrate high fat diet and reversed his T2DM within a year. Now he has one main goal in life and that is to make people understand that the conventional method of treating T2DM is not beneficial. Type 2 diabetes is reversible and the best way to reverse T2DM is through diet and lifestyle modifications. He now decided to help people with type 2 diabetes by offering online coaching to reverse their diabetes.